18 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Identification of SENP1 inhibitors through in silico screening and rational drug design.
Shanghai Jiao Tong University
Development and evaluation of a highly reliable assay for SUMO-specific protease inhibitors.
Shanghai Jiao Tong University
Spongiacidin C, a pyrrole alkaloid from the marine sponge Stylissa massa, functions as a USP7 inhibitor.
Kumamoto University
Discovery of 1-[4-(N-benzylamino)phenyl]-3-phenylurea derivatives as non-peptidic selective SUMO-sentrin specific protease (SENP)1 inhibitors.
Gakushuin University
2-(4-Chlorophenyl)-2-oxoethyl 4-benzamidobenzoate derivatives, a novel class of SENP1 inhibitors: Virtual screening, synthesis and biological evaluation.
Shanghai Jiao Tong University
Design, synthesis, and biological evaluation of benzodiazepine-based SUMO-specific protease 1 inhibitors.
Shanghai Jiao Tong University
Recent research and development of inhibitors targeting sentrin-specific protease 1 for the treatment of cancers.
Sichuan University
Discovery and radiosensitization research of ursolic acid derivatives as SENP1 inhibitors.
Peking Union Medical College
Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.
Peking Union Medical College
Small-molecule inhibitors targeting small ubiquitin-like modifier pathway for the treatment of cancers and other diseases.
China Pharmaceutical University
Benzothiophene-2-carboxamide derivatives as SENPs inhibitors with selectivity within SENPs family.
Shanghai Jiao Tong University
Vialinin A and thelephantin G, potent inhibitors of tumor necrosis factor-α production, inhibit sentrin/SUMO-specific protease 1 enzymatic activity.
Tokyo University of Agriculture
Apoptosis signal-regulating kinase inhibitors and uses thereof
Sichuan Haisco Pharmaceutical
Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as a-glucosidase inhibitors.
Jishou University